Log in

Current Evidence for Endovascular Therapies in the Management of Acute Deep Vein Thrombosis

  • Review
  • Venous Interventions
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Acute lower extremity deep vein thrombosis (DVT), specifically proximal iliofemoral DVT, is a relatively common disorder that can result in a chronic debilitating post-thrombotic syndrome (PTS), with a significant effect on a patient’s quality of life. Anticoagulation is first-line therapy; however, percutaneous interventions have emerged as treatment options for patients where there is concern that anticoagulation alone will not resolve the DVT as well as prevent PTS. This paper will discuss the existing data on these interventions and review current endovascular techniques, including catheter-directed thrombolysis, pharmacomechanical thrombectomy, and large-bore mechanical thrombectomy in the management of DVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Baekgaard N. Incidence and location of deep vein thrombosis in the lower extremies: what do we know? Phlebolymphology. 2017;24:97–104.

    Google Scholar 

  2. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4 Suppl):S495-501.

    Article  PubMed  Google Scholar 

  3. Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, et al. Endovascular thrombus removal for acute Iliofemoral deep vein thrombosis. Circulation. 2019;139(9):1162–73.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huynh N, Fares WH, Brownson K, Brahmandam A, Lee AI, Dardik A, et al. Risk factors for presence and severity of pulmonary embolism in patients with deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2018;6(1):7–12.

    Article  PubMed  Google Scholar 

  5. Obi A, Barnes GD. Continuing to advance the venous agenda: long-term insights from the CAVA trial. J Am Heart Assoc. 2021;10(11): e021659.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–52.

    Article  PubMed  Google Scholar 

  7. Dexter DKH, Shaikh A, Schor J, Annambhotla S, Zybulewski A. Safety and Effectiveness of Mechanical Thrombectomy From the Fully Enrolled Multicenter, Prospective CLOUT Registry. J Soc Cardiovasc Angiogr Interv. 2023;2(2): 100585.

    Google Scholar 

  8. Popuri RK, Vedantham S. The role of thrombolysis in the clinical management of deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2011;31(3):479–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Enden T, Haig Y, Klow NE, Slagsvold CE, Sandvik L, Ghanima W, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379(9810):31–8.

    Article  PubMed  Google Scholar 

  10. Haig Y, Enden T, Grotta O, Klow NE, Slagsvold CE, Ghanima W, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3(2):e64-71.

    Article  PubMed  Google Scholar 

  11. Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240–52.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Notten P, Ten Cate-Hoek AJ, Arnoldussen C, Strijkers RHW, de Smet A, Tick LW, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol. 2020;7(1):e40–9.

    Article  PubMed  Google Scholar 

  13. Enden T, Resch S, White C, Wik HS, Klow NE, Sandset PM. Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis. J Thromb Haemost. 2013;11(6):1032–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kearon C, Gu CS, Julian JA, Goldhaber SZ, Comerota AJ, Gornik HL, et al. Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis: analysis from a stratified randomized trial. Thromb Haemost. 2019;119(4):633–44.

    Article  PubMed  Google Scholar 

  15. Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med. 2001;110(7):515–9.

    Article  CAS  PubMed  Google Scholar 

  16. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149(10):698–707.

    Article  PubMed  Google Scholar 

  17. Kahn SR, Julian JA, Kearon C, Gu CS, Cohen DJ, Magnuson EA, et al. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;8(1):8–23.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Thukral S, Salter A, Lancia S, Kahn SR, Vedantham S. Predictors of clinical outcomes of pharmacomechanical catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: analysis of a multicenter randomized trial. J Vasc Interv Radiol. 2022;33(10):1161–70.

    Article  PubMed  Google Scholar 

  19. Notten P, de Smet A, Tick LW, van de Poel MHW, Wikkeling ORM, Vleming LJ, et al. CAVA (ultrasound-accelerated catheter-directed thrombolysis on preventing post-thrombotic syndrome) trial: long-term follow-up results. J Am Heart Assoc. 2021;10(11): e018973.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lichtenberg MKW, Stahlhoff S, Mlynczak K, Golicki D, Gagne P, Razavi MK, et al. Endovascular mechanical thrombectomy versus thrombolysis in patients with iliofemoral deep vein thrombosis - a systematic review and meta-analysis. Vasa. 2021;50(1):59–67.

    Article  PubMed  Google Scholar 

  21. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline. 2020. Available from: hhps://www.nice.org.uk/guidance/ng158

  22. Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, et al. Editor’s choice - european society for vascular surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg. 2021;61(1):9–82.

    Article  PubMed  Google Scholar 

  23. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e419S – e496.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–738.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Vedantham S, Desai KR, Weinberg I, Marston W, Winokur R, Patel S, et al. Society of interventional radiology position statement on the endovascular management of acute iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2023;34(2):284–99.

    Article  PubMed  Google Scholar 

  26. Engelberger RP, Spirk D, Willenberg T, Alatri A, Do DD, Baumgartner I, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv. 2015. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002027.

    Article  PubMed  Google Scholar 

  27. Engelberger RP, Stuck A, Spirk D, Willenberg T, Haine A, Periard D, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial. J Thromb Haemost. 2017;15(7):1351–60.

    Article  CAS  PubMed  Google Scholar 

  28. Vedantham S, Salter A, Lancia S, Lewis L, Thukral S, Kahn SR. Clinical Outcomes of a pharmacomechanical catheter-directed venous thrombolysis strategy that included rheolytic thrombectomy in a multicenter randomized trial. J Vasc Interv Radiol. 2021;32(9):1296–309.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Dopheide JF, Sebastian T, Engelberger RP, Haine A, Kucher N. Early clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis. Vasa. 2018;47(1):56–62.

    Article  PubMed  Google Scholar 

  30. Gong M, Fu G, Liu Z, Zhou Y, Kong J, Zhao B, et al. Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a solent omni catheter for patients with proximal vein thrombosis. Thromb J. 2023;21(1):25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Rohr AM, Kuo WT. Single-session pharmacomechanical catheter-directed thrombolysis using the JETi thrombectomy device for acute iliofemoral deep vein thrombosis refractory to therapeutic anticoagulation. J Vasc Interv Radiol. 2019;30(10):1682–5.

    Article  PubMed  Google Scholar 

  32. Razavi C, Khalsa B, Openshaw L, Razavi MK. Single-session treatment of patients with symptomatic iliocaval and iliofemoral deep vein thrombosis: technical results of a prospective pilot study. J Vasc Interv Radiol. 2022;33(2):183–8.

    Article  PubMed  Google Scholar 

  33. Dexter DJ, Kado H, Schor J, Annambhotla S, Olivieri B, Mojibian H, et al. Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-Comer CLOUT registry. J Vasc Surg Venous Lymphat Disord. 2022;10(4):832–40.

    Article  PubMed  Google Scholar 

  34. Dexter D. One-year interim outcomes of mechanical thrombectomy for deep vein thrombosis from the real-world CLOUT registry. Vasc Surg Venous Lymphat Disord. 2023;11(2):458–9.

    Article  Google Scholar 

  35. DEFIANCE: RCT of clottriever system versus anticoagulation in deep vein thrombosis.: clinicaltrials.gov identifier: NCT05701917. Available from: hhps://clinicaltrials.gov/ct2/show/NCT05701917.

  36. Lopez R, DeMartino R, Fleming M, Bjarnason H, Neisen M. Aspiration thrombectomy for acute iliofemoral or central deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2019;7(2):162–8.

    Article  PubMed  Google Scholar 

  37. Robertson B, Neville E, Muck A, Broering M, Kulwicki A, Kuhn B, et al. Technical success and short-term results from mechanical thrombectomy for lower extremity iliofemoral deep vein thrombosis using a computer aided mechanical aspiration thrombectomy device. J Vasc Surg Venous Lymphat Disord. 2022;10(3):594–601.

    Article  PubMed  Google Scholar 

  38. BOLT: study of the indigo® AspiraVon system when used in PaVents with deep vein thrombosis. Available from: hhps://clinicaltrials.gov/ct2/show/NCT05003843

  39. Owens CA, Bui JT, Knuttinen MG, Gaba RC, Carrillo TC. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol. 2010;21(6):779–87.

    Article  PubMed  Google Scholar 

  40. Ploton G, Pistorius MA, Raimbeau A, Denis Le Seve J, Bergere G, Ngohou C, et al. A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis. Medicine. 2020;99(6):e18996.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Yuen HLA, Tran H, Chunilal S. Upper extremity deep vein thrombosis: current knowledge and future directions. Semin Thromb Hemost. 2021;47(6):677–91.

    Article  PubMed  Google Scholar 

  42. Kahn SR, Elman EA, Bornais C, Blostein M, Wells PS. Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost. 2005;93(3):499–502.

    Article  CAS  PubMed  Google Scholar 

  43. Mai C, Hunt D. Upper-extremity deep venous thrombosis: a review. Am J Med. 2011;124(5):402–7.

    Article  PubMed  Google Scholar 

  44. Cote LP, Greenberg S, Caprini JA, Tafur A, Choi C, Munoz FJ, et al. Comparisons between upper and lower extremity deep vein thrombosis: a review of the RIETE registry. Clin Appl Thromb Hemost. 2017;23(7):748–54.

    Article  PubMed  Google Scholar 

  45. Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021;160(6):e545–608.

    Article  CAS  PubMed  Google Scholar 

  46. Feinberg J, Nielsen EE, Jakobsen JC. Thrombolysis for acute upper extremity deep vein thrombosis. Cochrane Database Syst Rev. 2017;12(12):CD012175.

    PubMed  Google Scholar 

  47. Thiyagarajah K, Ellingwood L, Endres K, Hegazi A, Radford J, Iansavitchene A, et al. Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: a systematic review and meta-analysis. Thromb Res. 2019;174:34–9.

    Article  CAS  PubMed  Google Scholar 

  48. Cai TY, Rajendran S, Saha P, Dubenec S. Paget-Schroetter syndrome: a contemporary review of the controversies in management. Phlebology. 2020;35(7):461–71.

    Article  PubMed  Google Scholar 

  49. Guzzo JL, Chang K, Demos J, Black JH, Freischlag JA. Preoperative thrombolysis and venoplasty affords no benefit in patency following first rib resection and scalenectomy for subacute and chronic subclavian vein thrombosis. J Vasc Surg. 2010;52(3):658–62.

    Article  PubMed  Google Scholar 

  50. van den Houten MM, van Grinsven R, Pouwels S, Yo LS, van Sambeek MR, Tei**k JA. Treatment of upper-extremity outflow thrombosis. Phlebology. 2016;31(1 Suppl):28–33.

    Article  PubMed  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adam N. Plotnik.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Consent for publication

For this type of study, consent for publication is not required.

Ethical Approval

For this type of study, formal consent is not required.

Informed Consent

For this type of study, informed consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Plotnik, A.N., Haber, Z. & Kee, S. Current Evidence for Endovascular Therapies in the Management of Acute Deep Vein Thrombosis. Cardiovasc Intervent Radiol (2024). https://doi.org/10.1007/s00270-024-03784-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00270-024-03784-z

Keywords

Navigation